Insights On Clinical Technologies

  1. The Impact Of Expert PK/PD Modeling In Psychedelic Research 12/2/2025

    Model-informed development that integrates preclinical and literature-based data is enabling smarter predictions of exposure and safety, transforming psychedelic research and advancing clinical innovation.

  2. Sensors And On-Demand eCOA 7/13/2026

    See how one rare disease trial eased caregiver burden by unifying glucose monitoring and patient diaries into a single app with real-time safety alerts.

  3. What Unified eCOA And IRT Can Unlock 4/6/2026

    See how real-time scoring and automated eligibility checks helped a global dermatology study reduce site burden, avoid manual errors, and move participants through screening with greater speed.

  4. The Future Of Patient Experience: Lessons From GLP-1 Studies 7/29/2026

    Improve adherence, retention, and data quality in GLP-1 and cardiometabolic trials through connected digital tools, real-time symptom tracking, caregiver support, and AI-assisted review.

  5. The Answer To Your Pharmacovigilance Challenges: AI-Powered Adverse Event Detection 11/7/2025

    A proven, AI-powered safety platform can accelerate adverse event detection and safety data extraction to ease the burden on safety professionals and better protect patients.

  6. 2025 Safety And Regulatory Compliance Trends And Predictions 12/16/2024

    Explore the rapidly evolving regulatory landscape that pharmaceutical and biotech industries face as they integrate AI and advanced technologies into safety, compliance, and lifecycle management.

  7. FDA Pushes For Patient Voice: ePRO In Oncology Trials 1/8/2026

    FDA urges sponsors and CROs to include patient voices in oncology trials. Discover why it matters and how to start integrating this approach.

  8. A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data 2/25/2025

    Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.

  9. The FDA's Remote Regulatory Assessments: The Future Of Inspections 1/31/2025

    Remote Regulatory Assessments (RRAs) provide distinct advantages over traditional inspections, such as increased efficiency, reduced travel costs, and enhanced global oversight capabilities.

  10. Unleash The Power Of IQVIA eCOA: A Deep Dive 9/10/2024

    Edward Bartels, an expert in eCOA solutions, provides an in-depth overview of the market trends, emerging technologies, and how IQVIA eCOA is pioneering advancements in this space.